EUR 15.55
(-4.01%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 21.79 Million EUR | 7.73% |
2022 | 16.06 Million EUR | -15.77% |
2021 | 19.77 Million EUR | 101.56% |
2020 | 10.58 Million EUR | -23.46% |
2019 | 11.21 Million EUR | 57.84% |
2018 | 8.81 Million EUR | 18.27% |
2017 | 7.82 Million EUR | 29.28% |
2016 | 5.78 Million EUR | -31.53% |
2015 | 7.25 Million EUR | 330.65% |
2014 | 1.57 Million EUR | 345.48% |
2013 | -642 Thousand EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 16.97 Million EUR | 0.0% |
2023 Q2 | 9.94 Million EUR | 0.0% |
2023 FY | - EUR | 7.73% |
2023 Q4 | -135.3 Million EUR | 0.0% |
2022 FY | - EUR | -15.77% |
2022 Q2 | 7.36 Million EUR | 0.0% |
2022 Q4 | 8.04 Million EUR | 0.0% |
2021 Q2 | 9.86 Million EUR | 0.0% |
2021 Q4 | 7.95 Million EUR | 0.0% |
2021 FY | - EUR | 101.56% |
2020 FY | - EUR | -23.46% |
2020 Q2 | 2.94 Million EUR | 0.0% |
2020 Q4 | 5.94 Million EUR | 0.0% |
2019 Q4 | 5.38 Million EUR | 0.0% |
2019 Q2 | 5.94 Million EUR | 0.0% |
2019 FY | - EUR | 57.84% |
2018 FY | - EUR | 18.27% |
2018 Q4 | 3.37 Million EUR | 0.0% |
2018 Q2 | 3.73 Million EUR | 0.0% |
2017 FY | - EUR | 29.28% |
2017 Q4 | 1.66 Million EUR | 0.0% |
2017 Q2 | 4.34 Million EUR | 0.0% |
2016 Q4 | 1.5 Million EUR | 0.0% |
2016 FY | - EUR | -31.53% |
2016 Q2 | 3.14 Million EUR | 0.0% |
2015 Q4 | 6.95 Million EUR | 0.0% |
2015 Q2 | -163.74 Thousand EUR | 0.0% |
2015 FY | - EUR | 330.65% |
2014 Q4 | 1.81 Million EUR | 41.14% |
2014 Q2 | 1.28 Million EUR | 0.0% |
2014 Q1 | 1.28 Million EUR | 0.0% |
2014 Q3 | 1.28 Million EUR | 0.0% |
2014 FY | - EUR | 345.48% |
2013 FY | - EUR | 0.0% |
2013 Q4 | 1.28 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 99.257% |
Fresenius SE & Co. KGaA | 2.73 Billion EUR | 99.203% |
LIMES Schlosskliniken AG | 854.98 Thousand EUR | -2448.91% |
Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -362.199% |
MEDICLIN Aktiengesellschaft | 101.26 Million EUR | 78.479% |
RHÖN-KLINIKUM Aktiengesellschaft | 116.58 Million EUR | 81.307% |
VITA 34 AG | 5.8 Million EUR | -275.348% |